DAWN SHARER: Open Payments
NPI 1649538752 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 48 payments from 16 companies in 2025. Trend: 2023 $1,674 · 2024 $2,313 · 2025 $1,326
Food & beverage: $1,231Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $301 |
| Organogenesis Inc. | 10 | $253 |
| LEO Pharma Inc. | 3 | $202 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $113 |
| Organon LLC | 3 | $54 |
| ABBVIE INC. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
Products named: TREMFYA, CYGNUS DUAL, ANZUPGO, ILUMYA, ADBRY, VTAMA, DUPIXENT, SPEVIGO.
Industry payments across MD — which companies pay providers there.
